采用流式细胞术对浸润性膀胱癌进行DNA倍体分析。
DNA ploidy analysis of invasive bladder cancer by flow cytometry.
作者信息
Badalament R A, Smith J J, Franklin G L, Drago J R
机构信息
Department of Surgery, Ohio State University, Columbus.
出版信息
In Vivo. 1990 Jul-Aug;4(4):269-72.
PMID:2103372
Abstract
Refinement in the treatment of invasive bladder cancer requires improved methods to predict the biologic behavior of tumors. Although DNA ploidy analysis represents an initial application of flow cytometry, it has proved to be a clinically useful test. Flow cytometric DNA ploidy analysis is compared to conventional prognostic indicators, and its current status in the management of patients with invasive bladder cancers is discussed.
摘要
浸润性膀胱癌治疗方法的改进需要有更好的方法来预测肿瘤的生物学行为。尽管DNA倍体分析是流式细胞术的最初应用，但已证明它是一项具有临床实用价值的检测。将流式细胞术DNA倍体分析与传统的预后指标进行比较，并讨论其在浸润性膀胱癌患者管理中的现状。
Zotero 插件